Used as a key intermediate in the semi-synthesis of anticancer drugs, particularly paclitaxel (taxol). It serves as a precursor in modifying the taxane core structure to enhance drug efficacy and reduce reliance on natural sources of taxol. Its hydroxyl group allows selective chemical modifications, enabling scalable production of derivatives for chemotherapy agents targeting ovarian, breast, and lung cancers. Also studied for improving solubility and bioavailability in next-generation taxane-based treatments.